Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Al Amal Hospital in Qatar Commences Treatments Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems

June 21, 2010 6:36 am | by Bio-Medicine.Org | News | Comments

DOHA, Qatar , June 21 /- One of the leading cancer centers in the Middle East has become among the first in the region to introduce fast and efficient RapidArc® radiotherapy treatments from Varian Medical Systems (NYSE: VAR). Al Amal Hospital in Doha, Qatar , has treated nine brain...

TOPICS:

U.S. FDA Approves Improved Performance of Riverain Medical's OnGuard Chest X-ray Computer-Aided Detection Technology

June 21, 2010 6:34 am | by Bio-Medicine.Org | News | Comments

DAYTON, Ohio , June 21 /- Riverain Medical® announced today that the U.S. Food and Drug Administration (FDA) has granted approval for the newest version of the OnGuard™ Chest X-ray Computer-Aided Detection (CAD) technology. OnGuard identifies solitary pulmonary nodules that may...

TOPICS:

New possibility to determine the severity of appendicitis

June 21, 2010 6:34 am | by EurekAlert | News | Comments

(University of Gothenburg) The symptoms of appendicitis are often diffuse and it can be difficult to obtain an accurate diagnosis early in the course of the disease. It may be possible to predict the severity from a blood sample, and in this way determine the treatment on an...

TOPICS:
Advertisement

BD and PEPFAR Collaboration Initiates Program to Improve Blood-Drawing Practices in Clinics and Hospitals in Sub-Saharan Africa

June 21, 2010 6:34 am | by Becton, Dickinson and Company | News | Comments

(June 21, 2010) -- BD (Becton, Dickinson and Company), a leading global medical technology company, and the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Department of Health and Human Services' Centers for Disease Control an

TOPICS:

ERT Announces New Report by TUFTS Identifying Growth in Adoption of Centralized ECG Services

June 21, 2010 6:34 am | by RealWire | News | Comments

PHILADELPHIA, 21 June 2010 - ERT, a global provider of technology and services to the pharmaceutical, biotechnology and medical device industries, announced today the availability of a new report, conducted by the Tufts Center for the Study of Drug Development, mapping the growing...

TOPICS:

CardioGenics Selects Clinical Test Sites for Its High Speed Portable Blood Analyzer

June 21, 2010 6:33 am | by Bio-Medicine.Org | News | Comments

MISSISSAUGA, Ontario , June 21 /- CardioGenics Holdings Inc. (OTC Bulletin Board: CGNH), developer of the ultra-sensitive QL Careâ„¢ Point-Of-Care (POC) analyzer and products for the immunoassay segment of the In-Vitro Diagnostics market, announced the selection of four sites for...

TOPICS:

Magic Power Coffee: Undeclared Drug Ingredient

June 21, 2010 6:30 am | by U.S. Food & Drug Administration | News | Comments

Product marketed as a dietary supplement for sexual enhancement contains the drug ingredient hydroxythiohomosildenafil, a chemical that may interact with prescription nitrates, and cause dangerously low blood pressure.

TOPICS:

Cardiovascular Devices Market Outlook June Update by ReportsandReports

June 21, 2010 4:37 am | by Bio-Medicine.Org | News | Comments

DALLAS , June 21, 2010 /- ReportsandReports announces it Will Carry Cardiovascular Devices Market Outlook 2016 June reports in its store. Netherlands Cardiovascular Devices Market Outlook to 2016 ( http://www.reportsandreports.com/market-reports/netherlands-cardiovascular-de...

TOPICS:
Advertisement

California Cryobank Welcomes New Director of Quality/Regulatory Affairs

June 21, 2010 4:37 am | by Bio-Medicine.Org | News | Comments

LOS ANGELES , June 21 /- California Cryobank (CCB), a worldwide leader in biotechnology services, is proud to announce the recent hiring of Rama Tyagi as the company's Director of Quality/Regulatory Affairs. Tyagi's hiring into the newly created position echoes CCB's ongoing commitment to...

TOPICS:

Boston Scientific Expands PolarCath® Peripheral Dilatation System With New Balloon Sizes

June 21, 2010 4:36 am | by Boston Scientific | News | Comments

Longer balloons provide physicians more options for treating peripheral artery disease

TOPICS:

Medco and Celesio Announce Pan-European Joint Venture to Enhance Quality of Clinical Care and Reduce Overall Healthcare Costs

June 21, 2010 1:34 am | by Bio-Medicine.Org | News | Comments

BERLIN , June 21 /- Medco Health Solutions, Inc. (NYSE: MHS ) and Celesio AG, two of the world's leading pharmacy-driven healthcare companies, today announced a joint venture with a long-term goal of improving patient health and helping to relieve the crushing financial burden on...

TOPICS:

Zydus' Novel Orally Administered GLP-1 Agonist - 'ZYOG1' to treat Diabetes and Obesity Enters Phase I Clinical Trial

June 20, 2010 10:34 pm | by Bio-Medicine.Org | News | Comments

AHMEDABAD, India , June 21, 2010 /- Zydus Cadila, a global healthcare provider and one of India's leading healthcare companies has received Phase I clinical trial permission from the DCGI for ZYOG1 - a novel GLP-1 agonist. Designed and developed at the Zydus Research Centre using a unique...

TOPICS:

Compost filter socks improve runoff from croplands

June 20, 2010 8:38 pm | by EurekAlert | News | Comments

(American Society of Agronomy) Study finds that compost filters socks can reduce soil erosion from croplands and reduce the amount of herbicide in runoff.

TOPICS:

Flame retardant linked to altered thyroid hormone levels during pregnancy

June 20, 2010 8:38 pm | by EurekAlert | News | Comments

(University of California - Berkeley) A new UC Berkeley-led study of pregnant women links higher blood levels of PBDEs, a common type of flame retardant, with altered thyroid hormone levels. Normal maternal thyroid levels are important for healthy fetal neurodevelopment.

TOPICS:

Drug Targets Lupus by Tricking Immune System

June 20, 2010 8:35 pm | by Massachusetts Institute of Technology | News | Comments

A new approach shows early promise in fighting the devastating disease.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading